These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 2369684

  • 41. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 42. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin.
    Smith CI, Aarli JA, Biberfeld P, Bolme P, Christensson B, Gahrton G, Hammarström L, Lefvert AK, Lönnqvist B, Matell G.
    N Engl J Med; 1983 Dec 22; 309(25):1565-8. PubMed ID: 6361555
    [No Abstract] [Full Text] [Related]

  • 43. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP, Horowitz MM.
    Bone Marrow Transplant; 1990 Jul 22; 6 Suppl 1():94-7. PubMed ID: 2390646
    [Abstract] [Full Text] [Related]

  • 44. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
    Sutton L, Kuentz M, Cordonnier C, Blaise D, Devergie A, Guyotat D, Leblond V, Flesch M, Bordigoni P, Attal M.
    Bone Marrow Transplant; 1993 Dec 22; 12(6):583-9. PubMed ID: 8136742
    [Abstract] [Full Text] [Related]

  • 45. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ, Tischler HJ, Ringe B, Raddatz G, Maschek H, Dietrich H, Kuse E, Pichlmayr R, Link H.
    Bone Marrow Transplant; 1995 Sep 22; 16(3):473-8. PubMed ID: 8535323
    [Abstract] [Full Text] [Related]

  • 46. Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation.
    Nagashima T, Sato F, Chuma T, Mano Y, Sasaki I, Mori M, Higa T, Masauji N, Kasai M, Orba Y, Shinohara T, Nagashima K.
    Neuropathology; 2002 Mar 22; 22(1):1-8. PubMed ID: 12030409
    [Abstract] [Full Text] [Related]

  • 47. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec 22; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 48. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS, Lie AK, Liang R, Au WY, Kwong YL.
    Bone Marrow Transplant; 2007 Aug 22; 40(4):339-47. PubMed ID: 17572712
    [Abstract] [Full Text] [Related]

  • 49. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun 22; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 50. Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review.
    Tsutsumi Y, Kamiishi T, Kikuchi R, Ito S, Matsuoka S, Teshima T.
    Hematol Oncol Stem Cell Ther; 2019 Jun 22; 12(2):110-114. PubMed ID: 28549768
    [Abstract] [Full Text] [Related]

  • 51. [Allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
    Yamauchi T, Ohno R.
    Nihon Rinsho; 1990 Sep 22; 48(9):2073-9. PubMed ID: 2232212
    [No Abstract] [Full Text] [Related]

  • 52. Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemia.
    Miyawaki Y, Imoto I, Tokairin Y, Kawada K, Nakajima Y, Nishikage T, Nagai K, Kajiwara M, Inazawa J, Kawano T.
    Jpn J Clin Oncol; 2013 Jan 22; 43(1):69-73. PubMed ID: 23225908
    [Abstract] [Full Text] [Related]

  • 53. Muscle-specific kinase-antibody-positive myasthenia gravis after autologous bone marrow transplantation.
    Grover KM, Sripathi N, Elias SB.
    J Clin Neuromuscul Dis; 2012 Mar 22; 13(3):146-8. PubMed ID: 22538309
    [Abstract] [Full Text] [Related]

  • 54. Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation.
    Kleinau I, Perez-Canto A, Schmid HJ, Grassot A, Staab D, Renz H, Henze G, Wahn U, Paul K.
    Bone Marrow Transplant; 1997 Apr 22; 19(8):841-4. PubMed ID: 9134179
    [Abstract] [Full Text] [Related]

  • 55. Myasthenia gravis after BMT: identification of patients at risk?
    Melms A, Faul C, Sommer N, Wiethölter H, Müller CA, Ehninger G.
    Bone Marrow Transplant; 1992 Jan 22; 9(1):78-9. PubMed ID: 1543956
    [No Abstract] [Full Text] [Related]

  • 56. Successful Single-Lung Transplant for Severe Lung Graft-Versus-Host Disease Two Years After Sibling Allograft for Acute Lymphoblastic Leukemia: A Case Report.
    Irhimeh MR, Musk M, Cooney JP.
    Transplant Proc; 2016 Nov 22; 48(9):3227-3230. PubMed ID: 27932188
    [Abstract] [Full Text] [Related]

  • 57. Demodicidosis simulating acute graft-versus-host disease after allogeneic stem cell transplantation in one patient with acute lymphoblastic leukemia.
    Román-Curto C, Meseguer-Yebra C, Cañueto J, Fraile-Alonso C, Santos-Briz A, Vázquez L, Fernández-López E.
    Transpl Infect Dis; 2012 Aug 22; 14(4):387-90. PubMed ID: 22487272
    [Abstract] [Full Text] [Related]

  • 58. Allogeneic bone marrow transplantation in acute lymphoblastic leukemia (ALL).
    Santos GW.
    Leukemia; 1992 Aug 22; 6 Suppl 2():198. PubMed ID: 1578933
    [No Abstract] [Full Text] [Related]

  • 59. Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells.
    Kotani A, Takahashi A, Koga H, Morita R, Fukuyama H, Ichinohe T, Ishikawa T, Hori T, Uchiyama T.
    Eur J Haematol; 2002 Aug 22; 69(5-6):318-20. PubMed ID: 12460238
    [Abstract] [Full Text] [Related]

  • 60. Epididymo-orchitis and central nervous system nocardiosis in a bone marrow transplant recipient for acute lymphoblastic leukemia.
    Dehghani M, Davarpanah MA.
    Exp Clin Transplant; 2009 Dec 22; 7(4):264-6. PubMed ID: 20353380
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.